This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vinorelbine and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (259)
Death (81)
Life Threatening Events (43)
Disability (3)
Reports by Reaction Type
Neutropenia (25),
Hepatic Failure (22),
Neutropenic Sepsis (21),
Febrile Neutropenia (20),
Pyrexia (18),
Pneumonia (18),
Anaemia (16),
Interstitial Lung Disease (15),
Pancytopenia (13),
Constipation (11),
Death (11),
Hypotension (11)
Below are a few examples of reports where side effects / adverse reactions may be related to Vinorelbine. For a complete list or a specific selection of reports, please use the links above.
Possible Vinorelbine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-27
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cisplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dexamethasone Sodium Phosphate
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Gemcitabine Hydrochloride
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Ifosfamide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Rituximab
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Vinblastine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Possible Vinorelbine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Dexamethasone
Possible Vinorelbine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Vinorelbine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Vinorelbine side effects in female
Reported by a pharmacist from United States on 2012-08-22
Patient: female, weighing 51.3 kg (112.8 pounds)
Reactions: Arthralgia, Nausea, Groin Pain
Drug(s) suspected as cause:
Vinorelbine
Indication: non-Small Cell Lung Cancer Stage IV
Vinorelbine Tartrate
Indication: non-Small Cell Lung Cancer Stage IV
Possible Vinorelbine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-21
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Vinorelbine side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-15
Patient: 68 year old female
Reactions: Neoplasm Malignant, Pulmonary Embolism
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cetuximab
Dosage: strength 2mg/ml. most recent infusion 21apr06
Indication: non-Small Cell Lung Cancer
Start date: 2006-01-19
Cisplatin
Dosage: most recent infusion 06apr06. received 4 infusions
Indication: non-Small Cell Lung Cancer
Start date: 2006-01-19
Vinorelbine
Dosage: most recent infusion 13apr06. received 8 infusions
Indication: non-Small Cell Lung Cancer
Start date: 2006-01-19
Possible Vinorelbine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Vinorelbine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Vinorelbine side effects in 38 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-09
Patient: 38 year old male
Reactions: Cellulitis, Febrile Neutropenia, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cetuximab
Dosage: delayed on 30-nov-05. most recent infusion 24-nov-05 (6th infusion).
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-20
Cisplatin
Dosage: most recent infusion 18-nov-05 (2nd infusion).
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-20
Vinorelbine
Dosage: most recent infusion 24-nov-05 (4th infusion).
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-20
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-08-08
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-30
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-08-30
Possible Vinorelbine side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-06
Patient: 60 year old male
Reactions: Extravasation
Drug(s) suspected as cause:
Vinorelbine
Other drugs received by patient: Cisplatin
Possible Vinorelbine side effects in 74 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-06
Patient: 74 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Diverticulitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cetuximab
Dosage: cetuximab 5mg/ml
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-13
End date: 2012-01-31
Cisplatin
Dosage: recent inf on 24-jan-2012
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-13
End date: 2012-01-24
Gemcitabine Hydrochloride
Dosage: 1 and day 8 of each 3-week cycle
Indication: non-Small Cell Lung Cancer
Start date: 2011-12-13
End date: 2012-01-31
Vinorelbine
Dosage: 1 and day 8 of each 3week cycle
Indication: non-Small Cell Lung Cancer
Other drugs received by patient: Isoten; Spiriva; Medrol; Voltaren; Minocycline HCL; Acetaminophen; Omeprazole; Ultra-MG; Duragesic-100; Litican; Primperan TAB
Possible Vinorelbine side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-06
Patient: male
Reactions: Gastric Perforation, Gastric Ulcer Haemorrhage, Anal Haemorrhage, Gastrointestinal Necrosis, Gastric Ulcer, Abdominal Pain Upper, Peritonitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Radiotherapy
Indication: Adrenal Mass
Vinorelbine
Dosage: 25 mg/m2, unk
Indication: Adrenal Mass
Possible Vinorelbine side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-03
Patient: 58 year old male
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Drug(s) suspected as cause:
Cetuximab
Dosage: no of courses 12
Indication: non-Small Cell Lung Cancer
Start date: 2011-10-24
Cisplatin
Dosage: no of courses 4
Indication: non-Small Cell Lung Cancer
Start date: 2011-10-24
Vinorelbine
Dosage: no of courses 8
Indication: non-Small Cell Lung Cancer
Start date: 2011-10-24
Other drugs received by patient: Emend; Dexamethasone; Ranitidine; Ondansetron; Prochlorperazine; Multi-Vitamin
Possible Vinorelbine side effects in 66 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-02
Patient: 66 year old male, weighing 77.0 kg (169.4 pounds)
Reactions: Febrile Bone Marrow Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cetuximab
Dosage: cetuximab 5mg/ml recent dose 250mg/m2,inf 14, 10may12
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-31
Cisplatin
Dosage: recent dose 80mg/m2, on 3may12 inf 5,
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-31
Vinorelbine
Dosage: 25mg/m2 day 1 and day 8 of each 3wk cycle. recent dose 25mg/m2, inf 10, 10may12
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-31
Possible Vinorelbine side effects in female
Reported by a physician from Spain on 2012-07-31
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Pulmonary Toxicity, Organising Pneumonia, Respiratory Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer Metastatic
Start date: 2012-02-16
End date: 2012-03-01
Herceptin
Start date: 2012-03-29
End date: 2012-03-29
Taxol
Indication: Breast Cancer Metastatic
Start date: 2012-01-25
End date: 2012-03-01
Vinorelbine
Indication: Breast Cancer Metastatic
Start date: 2012-03-29
End date: 2012-03-29
Possible Vinorelbine side effects in female
Reported by a physician from Japan on 2012-07-31
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Subdural Haematoma, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2012-07-24
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-13
End date: 2012-07-13
Comparator Trastuzumab
Indication: Breast Cancer
Start date: 2012-03-13
End date: 2012-07-19
Comparator Trastuzumab
Start date: 2012-07-24
Vinorelbine
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
End date: 2012-07-19
Vinorelbine
Start date: 2012-07-24
Zoledronic Acid
Indication: Metastases To Bone
Start date: 2011-05-01
Other drugs received by patient: Loxoprofen; Lansoprazole; Rebamipide; Lyrica; Fentanyl-100; Magmitt
Possible Vinorelbine side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-07-26
Patient: 34 year old female
Reactions: Vomiting, Nausea, Hyperphosphataemia, Headache, Hypercalcaemia, Grand MAL Convulsion, Posterior Reversible Encephalopathy Syndrome, Dizziness, Altered State of Consciousness, Hypertension, Oxygen Saturation Decreased, Gaze Palsy
Drug(s) suspected as cause:
Vinorelbine
Other drugs received by patient: Paclitaxel; Cisplatin; Gemcitabine
Possible Vinorelbine side effects in female
Reported by a physician from Japan on 2012-07-25
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Subdural Haematoma, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-13
End date: 2012-07-13
Comparator Trastuzumab
Dosage: unk
Start date: 2012-03-13
Vinorelbine
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
Zoledronic Acid
Dosage: unk
Indication: Metastases To Bone
Start date: 2012-03-13
Other drugs received by patient: Loxoprofen; Lansoprazole; Lyrica; Rebamipide; Magmitt; Fentanyl-100
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-07-25
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-29
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-28
Possible Vinorelbine side effects in 33 year old male
Reported by a physician from Ireland on 2012-07-25
Patient: 33 year old male
Reactions: Fatigue, Drug Ineffective, Snoring, Gait Disturbance, Somnolence, Amnesia
Drug(s) suspected as cause:
Adcetris
Dosage: qcycle
Indication: Hodgkin's Disease
Gemcitabine
Dosage: qcycle
Indication: Hodgkin's Disease
Ifosfamide
Dosage: qcycle
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Possible Vinorelbine side effects in female
Reported by a physician from Spain on 2012-07-24
Patient: female
Reactions: Pulmonary Toxicity, Respiratory Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer Metastatic
Taxol
Indication: Breast Cancer Metastatic
Vinorelbine
Indication: Breast Cancer Metastatic
Possible Vinorelbine side effects in female
Reported by a physician from Japan on 2012-07-19
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Subdural Haematoma, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-13
Comparator Trastuzumab
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
Vinorelbine
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
Zoledronic Acid
Dosage: unk
Indication: Metastases To Bone
Start date: 2012-03-13
Other drugs received by patient: Magmitt; Loxoprofen; Rebamipide; Lansoprazole; Lyrica; Fentanyl-100
Possible Vinorelbine side effects in 56 year old male
Reported by a physician from Greece on 2012-07-18
Patient: 56 year old male
Reactions: Pneumonia Aspiration, Metastases To Liver, Metastases To Lung, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bevacizumab
Dosage: 15 mg/kg, every 21 days
Indication: non-Small Cell Lung Cancer
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Vinorelbine
Dosage: unk
Indication: non-Small Cell Lung Cancer
Other drugs received by patient: Docetaxel; Cisplatin
Possible Vinorelbine side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-16
Patient: 58 year old male
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Drug(s) suspected as cause:
Cetuximab
Dosage: no of courses 12
Indication: non-Small Cell Lung Cancer
Cisplatin
Dosage: no of courses 4
Indication: non-Small Cell Lung Cancer
Vinorelbine
Dosage: no of courses 8
Indication: non-Small Cell Lung Cancer
Other drugs received by patient: Prochlorperazine; Ranitidine; Emend; Ondansetron; Dexamethasone; Multi-Vitamin
Possible Vinorelbine side effects in female
Reported by a physician from Belgium on 2012-07-11
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Cytolytic Hepatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: code not broken
Indication: Breast Cancer Metastatic
Start date: 2011-07-01
End date: 2011-07-21
Afinitor
Dosage: no treatment
Start date: 2011-07-22
End date: 2011-08-04
Afinitor
Dosage: code not broken
Start date: 2011-08-05
End date: 2011-09-06
Blinded NO Treatment Received
Dosage: code not broken
Start date: 2011-08-05
End date: 2011-09-06
Blinded NO Treatment Received
Dosage: no treatment
Start date: 2011-07-22
End date: 2011-08-04
Blinded NO Treatment Received
Dosage: code not broken
Indication: Breast Cancer Metastatic
Start date: 2011-07-01
End date: 2011-07-21
Comparator Trastuzumab
Dosage: 2 mg/kg, unk
Indication: Breast Cancer Metastatic
Placebo
Dosage: no treatment
Start date: 2011-07-22
End date: 2011-08-04
Placebo
Dosage: code not broken
Indication: Breast Cancer Metastatic
Start date: 2011-07-01
End date: 2011-07-21
Placebo
Dosage: code not broken
Start date: 2011-08-05
End date: 2011-09-06
Pravastatin
Vinorelbine
Dosage: 2.5 mg/m2, unk
Indication: Breast Cancer Metastatic
Start date: 2011-07-01
Possible Vinorelbine side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10
Patient: 57 year old male
Reactions: Wrong Technique in Drug Usage Process, Neutropenic Sepsis, Skin Tightness, Incorrect Drug Administration Duration, Infusion Site Pain, Infusion Site Pruritus, Infusion Site Vesicles, Infusion Site Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Other drugs received by patient: Cisplatin
Possible Vinorelbine side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-10
Patient: 61 year old female
Reactions: Nausea, Pain, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2005-12-28
Erbitux
Indication: non-Small Cell Lung Cancer
Start date: 2005-12-28
Vinorelbine
Indication: non-Small Cell Lung Cancer
Start date: 2005-12-28
Other drugs received by patient: Domperidone; Ventolin; Granisetron; Magnesium Chloride; Potassium Chloride; Cyclizine; Tramadol HCL
Possible Vinorelbine side effects in
Reported by a physician from United States on 2012-07-09
Patient:
Reactions: Radiation Pneumonitis, Hodgkin's Disease
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: salvage chemotherapy
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: salvage chemotherapy
Doxorubicin HCL
Indication: Hodgkin's Disease
Etoposide
Etoposide
Indication: Hodgkin's Disease
Gemcitabine
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Radiotherapy
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
|